Role of long non-coding RNAs in disease progression of early stage unmutated chronic lymphocytic leukemia

por Tschumper, Renee C., Shanafelt, Tait D., Kay, Neil E., Jelinek, Diane F.
Publicado 2019

Multiple myeloma cell-derived microvesicles are enriched in CD147 expression and enhance tumor cell proliferation

por Arendt, Bonnie K., Walters, Denise K., Wu, Xiaosheng, Tschumper, Renee C., Jelinek, Diane F.
Publicado 2014

Selective Induction of DNA Repair Pathways in Human B Cells Activated by CD4(+) T Cells

por Wu, Xiaosheng, Tschumper, Renee C., Gutierrez, Albert, Mihalcik, Stephen A., Nowakowski, Grzegorz S., Jelinek, Diane F.
Publicado 2010

Differentiation of Chronic Lymphocytic Leukemia B Cells into Immunoglobulin Secreting Cells Decreases LEF-1 Expression

por Gutierrez, Albert, Arendt, Bonnie K., Tschumper, Renee C., Kay, Neil E., Zent, Clive S., Jelinek, Diane F.
Publicado 2011

Induction of Malignant Plasma Cell Proliferation by Eosinophils

por Wong, Tina W., Kita, Hirohito, Hanson, Curtis A., Walters, Denise K., Arendt, Bonnie K., Jelinek, Diane F.
Publicado 2013

Stage-Specific Non-Coding RNA Expression Patterns during In Vitro Human B Cell Differentiation into Antibody Secreting Plasma Cells

por Tschumper, Renee C., Hoelzinger, Dominique B., Walters, Denise K., Davila, Jaime I., Osborne, Collin A., Jelinek, Diane F.
Publicado 2022

Comprehensive Assessment of Potential Multiple Myeloma Immunoglobulin Heavy Chain V-D-J Intraclonal Variation Using Massively Parallel Pyrosequencing

por Tschumper, Renee C., Asmann, Yan W., Hossain, Asif, Huddleston, Paul M., Wu, Xiaosheng, Dispenzieri, Angela, Eckloff, Bruce W., Jelinek, Diane F.
Publicado 2012

Extracellular vesicle proteomic analysis leads to the discovery of HDGF as a new factor in multiple myeloma biology

por Hoelzinger, Dominique B., Quinton, Sophia J., Walters, Denise K., Vardam-Kaur, Trupti, Tschumper, Renee C., Borges da Silva, Henrique, Jelinek, Diane F.
Publicado 2022

Categorisation of patients based on immune profiles: a new approach to identifying candidates for response to checkpoint inhibitors

por Bornschlegl, Svetlana, Gustafson, Michael P, Delivanis, Danae A, Ryder, Mabel, Liu, Minetta C, Vasmatzis, George, Hallemeier, Chris L, Park, Sean S, Roberts, Lewis R, Parney, Ian F, Jelinek, Diane F, Dietz, Allan B
Publicado 2021

B cell receptor signaling drives APOBEC3 expression via direct enhancer regulation in chronic lymphocytic leukemia B cells

por Wang, Zhiquan, Yan, Huihuang, Boysen, Justin C., Secreto, Charla R., Tschumper, Renee C., Ali, Dania, Guo, Qianqian, Zhong, Jian, Zhou, Jiaqi, Gan, Haiyun, Yu, Chuanhe, Jelinek, Diane F., Slager, Susan L., Parikh, Sameer A., Braggio, Esteban, Kay, Neil E.
Publicado 2022

Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial

por Shanafelt, Tait D., Wang, Xin Victoria, Hanson, Curtis A., Paietta, Elisabeth M., O’Brien, Susan, Barrientos, Jacqueline, Jelinek, Diane F., Braggio, Esteban, Leis, Jose F., Zhang, Cong Christine, Coutre, Steven E., Barr, Paul M., Cashen, Amanda F., Mato, Anthony R., Singh, Avina K., Mullane, Michael P., Little, Richard F., Erba, Harry, Stone, Richard M., Litzow, Mark, Tallman, Martin, Kay, Neil E.
Publicado 2022